(Q44918524)

7 December 2017

title

The urologist view of BPH progression: results of an international survey (English)

1 reference

7 December 2017

Djavan B

1

1 reference

7 December 2017

Nickel JC

series ordinal

2

1 reference

7 December 2017

de la Rosette J

series ordinal

3

1 reference

7 December 2017

Abrams P

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

7 December 2017

1 reference

7 December 2017

volume

41

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

490-496

1 reference

The development of human benign prostatic hyperplasia with age

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

The Natural History of Untreated “Prostatism”

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

Natural history of prostatism: risk factors for acute urinary retention

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

Longitudinal changes in peak urinary flow rates in a community based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

The progression of benign prostatic hyperplasia: examining the evidence and determining the risk

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

The natural history of untreated lower urinary tract symptoms in middle-aged and elderly men over a period of five years

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900065-9

7 January 2021

10.1016/S0302-2838(02)00065-9

Identifiers

DOI

1 reference

7 December 2017

1 reference